Geron Corporation Logo

Geron Corporation

GERN

(0.5)
Stock Price

4,42 USD

-42.25% ROA

-63.31% ROE

-6.81x PER

Market Cap.

1.113.281.200,00 USD

19.28% DER

0% Yield

-77670.89% NPM

Geron Corporation Stock Analysis

Geron Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Geron Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (19%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

The stock's ROE indicates a negative return (-70.15%) on shareholders' equity, suggesting poor financial performance.

3 ROA

The stock's ROA (-42.25%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's elevated P/BV ratio (3.93x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Geron Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Geron Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Geron Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Geron Corporation Revenue
Year Revenue Growth
1996 5.300.000
1997 7.300.000 27.4%
1998 6.800.000 -7.35%
1999 5.400.000 -25.93%
2000 6.609.000 18.29%
2001 3.620.000 -82.57%
2002 1.248.000 -190.06%
2003 1.174.000 -6.3%
2004 1.053.000 -11.49%
2005 290.000 -263.1%
2006 3.277.000 91.15%
2007 7.622.000 57.01%
2008 2.803.000 -171.92%
2009 1.726.000 -62.4%
2010 3.563.000 51.56%
2011 2.438.000 -46.14%
2012 2.709.000 10%
2013 1.283.000 -111.15%
2014 1.153.000 -11.27%
2015 36.371.000 96.83%
2016 6.162.000 -490.25%
2017 1.065.000 -478.59%
2018 1.066.000 0.09%
2019 460.000 -131.74%
2020 253.000 -81.82%
2021 1.393.000 81.84%
2022 596.000 -133.72%
2023 656.000 9.15%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Geron Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1996 14.300.000
1997 15.100.000 5.3%
1998 15.600.000 3.21%
1999 20.600.000 24.27%
2000 23.548.000 12.52%
2001 29.018.000 18.85%
2002 31.573.000 8.09%
2003 25.551.000 -23.57%
2004 30.084.000 15.07%
2005 35.080.000 14.24%
2006 41.234.000 14.92%
2007 54.624.000 24.51%
2008 53.664.000 -1.79%
2009 57.617.000 6.86%
2010 61.687.000 6.6%
2011 69.316.000 11.01%
2012 51.368.000 -34.94%
2013 23.155.000 -121.84%
2014 20.707.000 -11.82%
2015 17.831.000 -16.13%
2016 18.047.000 1.2%
2017 11.033.000 -63.57%
2018 13.432.000 17.86%
2019 52.072.000 74.2%
2020 51.488.000 -1.13%
2021 85.727.000 39.94%
2022 95.518.000 10.25%
2023 117.704.000 18.85%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Geron Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 3.200.000
1997 3.100.000 -3.23%
1998 3.800.000 18.42%
1999 5.600.000 32.14%
2000 9.273.000 39.61%
2001 9.621.000 3.62%
2002 5.375.000 -79%
2003 5.803.000 7.38%
2004 7.104.000 18.31%
2005 8.788.000 19.16%
2006 9.403.000 6.54%
2007 15.837.000 40.63%
2008 16.183.000 2.14%
2009 14.343.000 -12.83%
2010 18.043.000 20.51%
2011 23.789.000 24.15%
2012 20.397.000 -16.63%
2013 15.624.000 -30.55%
2014 16.758.000 6.77%
2015 17.793.000 5.82%
2016 18.761.000 5.16%
2017 19.287.000 2.73%
2018 18.707.000 -3.1%
2019 20.893.000 10.46%
2020 25.678.000 18.63%
2021 29.665.000 13.44%
2022 43.628.000 32%
2023 73.400.000 40.56%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Geron Corporation EBITDA
Year EBITDA Growth
1996 -12.800.000
1997 -11.100.000 -15.32%
1998 -13.600.000 18.38%
1999 6.300.000 315.87%
2000 -21.559.000 129.22%
2001 -18.739.000 -15.05%
2002 -31.110.000 39.77%
2003 -25.279.000 -23.07%
2004 12.920.000 295.66%
2005 -39.835.000 132.43%
2006 -53.192.000 25.11%
2007 -76.362.000 30.34%
2008 -65.040.000 -17.41%
2009 -70.391.000 7.6%
2010 -41.357.000 -70.2%
2011 -82.617.000 49.94%
2012 -65.959.000 -25.26%
2013 -36.225.000 -82.08%
2014 -35.939.000 -0.8%
2015 1.424.000 2623.81%
2016 -29.454.000 104.83%
2017 -27.839.000 -5.8%
2018 -32.533.000 14.43%
2019 -72.505.000 55.13%
2020 -74.917.000 3.22%
2021 -111.589.000 32.86%
2022 -135.019.000 17.35%
2023 -190.448.000 29.1%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Geron Corporation Gross Profit
Year Gross Profit Growth
1996 6.500.000
1997 8.900.000 26.97%
1998 8.500.000 -4.71%
1999 9.100.000 6.59%
2000 11.262.000 19.2%
2001 3.620.000 -211.1%
2002 1.248.000 -190.06%
2003 1.174.000 -6.3%
2004 1.053.000 -11.49%
2005 290.000 -263.1%
2006 3.277.000 91.15%
2007 7.622.000 57.01%
2008 2.803.000 -171.92%
2009 1.726.000 -62.4%
2010 3.563.000 51.56%
2011 2.438.000 -46.14%
2012 2.709.000 10%
2013 1.283.000 -111.15%
2014 1.153.000 -11.27%
2015 36.371.000 96.83%
2016 6.162.000 -490.25%
2017 1.065.000 -478.59%
2018 1.066.000 0.09%
2019 460.000 -131.74%
2020 253.000 -81.82%
2021 1.393.000 81.84%
2022 596.000 -133.72%
2023 656.000 9.15%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Geron Corporation Net Profit
Year Net Profit Growth
1996 -10.700.000
1997 -9.600.000 -11.46%
1998 -10.800.000 11.11%
1999 -46.400.000 76.72%
2000 -45.833.000 -1.24%
2001 -42.073.000 -8.94%
2002 -33.908.000 -24.08%
2003 -29.883.000 -13.47%
2004 -80.405.000 62.83%
2005 -33.528.000 -139.81%
2006 -31.365.000 -6.9%
2007 -36.697.000 14.53%
2008 -62.021.000 40.83%
2009 -70.184.000 11.63%
2010 -111.377.000 36.99%
2011 -96.853.000 -15%
2012 -68.881.000 -40.61%
2013 -38.379.000 -79.48%
2014 -35.670.000 -7.59%
2015 46.000 77643.48%
2016 -29.537.000 100.16%
2017 -27.916.000 -5.81%
2018 -27.017.000 -3.33%
2019 -63.551.000 57.49%
2020 -75.610.000 15.95%
2021 -120.952.000 37.49%
2022 -141.033.000 14.24%
2023 -179.220.000 21.31%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Geron Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 -2
1997 -1 0%
1998 -1 0%
1999 -3 100%
2000 -2 -50%
2001 -2 -100%
2002 -1 0%
2003 -1 0%
2004 -2 100%
2005 -1 0%
2006 0 0%
2007 0 0%
2008 -1 0%
2009 -1 0%
2010 -1 100%
2011 -1 0%
2012 -1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Geron Corporation Free Cashflow
Year Free Cashflow Growth
1996 -11.000.000
1997 -8.600.000 -27.91%
1998 -8.800.000 2.27%
1999 -16.300.000 46.01%
2000 -14.786.000 -10.24%
2001 -23.529.000 37.16%
2002 -31.671.000 25.71%
2003 -24.807.000 -27.67%
2004 -27.451.000 9.63%
2005 -22.255.000 -23.35%
2006 -27.158.000 18.05%
2007 -29.622.000 8.32%
2008 -44.322.000 33.17%
2009 -44.809.000 1.09%
2010 -45.128.000 0.71%
2011 -63.004.000 28.37%
2012 -56.008.000 -12.49%
2013 -36.683.000 -52.68%
2014 9.219.000 497.91%
2015 -24.286.000 137.96%
2016 -18.426.000 -31.8%
2017 -20.556.000 10.36%
2018 -21.025.000 2.23%
2019 -44.242.000 52.48%
2020 -67.053.000 34.02%
2021 -95.763.000 29.98%
2022 -127.810.000 25.07%
2023 -51.031.000 -150.46%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Geron Corporation Operating Cashflow
Year Operating Cashflow Growth
1996 -9.900.000
1997 -7.900.000 -25.32%
1998 -7.800.000 -1.28%
1999 -13.600.000 42.65%
2000 -13.605.000 0.04%
2001 -22.423.000 39.33%
2002 -31.343.000 28.46%
2003 -24.396.000 -28.48%
2004 -25.925.000 5.9%
2005 -20.613.000 -25.77%
2006 -26.379.000 21.86%
2007 -26.632.000 0.95%
2008 -41.985.000 36.57%
2009 -43.374.000 3.2%
2010 -44.292.000 2.07%
2011 -62.392.000 29.01%
2012 -55.146.000 -13.14%
2013 -36.680.000 -50.34%
2014 9.350.000 492.3%
2015 -24.196.000 138.64%
2016 -18.369.000 -31.72%
2017 -20.556.000 10.64%
2018 -21.009.000 2.16%
2019 -43.829.000 52.07%
2020 -66.652.000 34.24%
2021 -95.556.000 30.25%
2022 -127.379.000 24.98%
2023 -50.839.000 -150.55%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Geron Corporation Capital Expenditure
Year Capital Expenditure Growth
1996 1.100.000
1997 700.000 -57.14%
1998 1.000.000 30%
1999 2.700.000 62.96%
2000 1.181.000 -128.62%
2001 1.106.000 -6.78%
2002 328.000 -237.2%
2003 411.000 20.19%
2004 1.526.000 73.07%
2005 1.642.000 7.06%
2006 779.000 -110.78%
2007 2.990.000 73.95%
2008 2.337.000 -27.94%
2009 1.435.000 -62.86%
2010 836.000 -71.65%
2011 612.000 -36.6%
2012 862.000 29%
2013 3.000 -28633.33%
2014 131.000 97.71%
2015 90.000 -45.56%
2016 57.000 -57.89%
2017 0 0%
2018 16.000 100%
2019 413.000 96.13%
2020 401.000 -2.99%
2021 207.000 -93.72%
2022 431.000 51.97%
2023 192.000 -124.48%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Geron Corporation Equity
Year Equity Growth
1996 23.600.000
1997 21.100.000 -11.85%
1998 32.800.000 35.67%
1999 26.200.000 -25.19%
2000 63.918.000 59.01%
2001 61.542.000 -3.86%
2002 29.741.000 -106.93%
2003 106.324.000 72.03%
2004 122.063.000 12.89%
2005 190.705.000 35.99%
2006 173.919.000 -9.65%
2007 205.674.000 15.44%
2008 168.455.000 -22.09%
2009 172.577.000 2.39%
2010 192.735.000 10.46%
2011 146.603.000 -31.47%
2012 85.653.000 -71.16%
2013 59.757.000 -43.34%
2014 130.712.000 54.28%
2015 142.126.000 8.03%
2016 122.380.000 -16.13%
2017 103.797.000 -17.9%
2018 177.733.000 41.6%
2019 135.155.000 -31.5%
2020 210.947.000 35.93%
2021 126.416.000 -66.87%
2022 79.998.000 -58.02%
2023 290.614.000 72.47%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Geron Corporation Assets
Year Assets Growth
1996 28.800.000
1997 26.100.000 -10.34%
1998 44.500.000 41.35%
1999 63.700.000 30.14%
2000 114.030.000 44.14%
2001 96.231.000 -18.5%
2002 60.669.000 -58.62%
2003 118.115.000 48.64%
2004 131.873.000 10.43%
2005 201.243.000 34.47%
2006 220.800.000 8.86%
2007 218.896.000 -0.87%
2008 176.218.000 -24.22%
2009 180.382.000 2.31%
2010 233.584.000 22.78%
2011 160.047.000 -45.95%
2012 99.801.000 -60.37%
2013 67.344.000 -48.2%
2014 172.511.000 60.96%
2015 148.760.000 -15.97%
2016 130.249.000 -14.21%
2017 110.313.000 -18.07%
2018 185.284.000 40.46%
2019 165.517.000 -11.94%
2020 270.728.000 38.86%
2021 226.034.000 -19.77%
2022 190.575.000 -18.61%
2023 413.017.000 53.86%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Geron Corporation Liabilities
Year Liabilities Growth
1996 5.200.000
1997 5.000.000 -4%
1998 11.700.000 57.26%
1999 37.500.000 68.8%
2000 50.112.000 25.17%
2001 34.689.000 -44.46%
2002 30.928.000 -12.16%
2003 11.791.000 -162.3%
2004 9.810.000 -20.19%
2005 10.538.000 6.91%
2006 46.881.000 77.52%
2007 13.222.000 -254.57%
2008 7.763.000 -70.32%
2009 7.805.000 0.54%
2010 40.849.000 80.89%
2011 13.444.000 -203.85%
2012 14.148.000 4.98%
2013 7.587.000 -86.48%
2014 41.799.000 81.85%
2015 6.634.000 -530.07%
2016 7.869.000 15.69%
2017 6.516.000 -20.76%
2018 7.551.000 13.71%
2019 30.362.000 75.13%
2020 59.781.000 49.21%
2021 99.618.000 39.99%
2022 110.577.000 9.91%
2023 122.403.000 9.66%

Geron Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.3
Price to Earning Ratio
-6.81x
Price To Sales Ratio
3511.93x
POCF Ratio
-7.33
PFCF Ratio
-6.83
Price to Book Ratio
4.09
EV to Sales
3591.77
EV Over EBITDA
-6.64
EV to Operating CashFlow
-7.03
EV to FreeCashFlow
-6.99
Earnings Yield
-0.15
FreeCashFlow Yield
-0.15
Market Cap
1,11 Bil.
Enterprise Value
1,14 Bil.
Graham Number
1.84
Graham NetNet
0.35

Income Statement Metrics

Net Income per Share
-0.3
Income Quality
0.93
ROE
-0.7
Return On Assets
-0.47
Return On Capital Employed
-0.68
Net Income per EBT
1
EBT Per Ebit
0.95
Ebit per Revenue
-818.33
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
194.25
Research & Developement to Revenue
379.64
Stock Based Compensation to Revenue
51.41
Gross Profit Margin
-126.4
Operating Profit Margin
-818.33
Pretax Profit Margin
-776.91
Net Profit Margin
-776.71

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.28
Free CashFlow per Share
-0.28
Capex to Operating CashFlow
0.01
Capex to Revenue
-2.86
Capex to Depreciation
-0.89
Return on Invested Capital
-0.52
Return on Tangible Assets
-0.42
Days Sales Outstanding
16988.04
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0.02
Payables Turnover
0
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,54
Book Value per Share
0,50
Tangible Book Value per Share
0.5
Shareholders Equity per Share
0.5
Interest Debt per Share
0.1
Debt to Equity
0.19
Debt to Assets
0.14
Net Debt to EBITDA
-0.15
Current Ratio
3.75
Tangible Asset Value
0,29 Bil.
Net Current Asset Value
0,21 Bil.
Invested Capital
0.19
Working Capital
0,25 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
535500
Debt to Market Cap
0.05

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Geron Corporation Dividends
Year Dividends Growth

Geron Corporation Profile

About Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

CEO
Dr. John A. Scarlett M.D.
Employee
141
Address
919 East Hillsdale Boulevard
Foster City, 94404

Geron Corporation Executives & BODs

Geron Corporation Executives & BODs
# Name Age
1 Mr. Scott Samuels
Executive Vice President, Chief Legal Officer & Corporate Secretary
70
2 Mr. Anil Kapur
Executive Vice President of Corporate Strategy & Chief Commercial Officer
70
3 Mr. Edward E. Koval
Executive Vice President & Chief Business Officer
70
4 Ms. Michelle J. Robertson
Executive Vice President, Chief Financial Officer, Treasurer and Principal Financial & Accounting Officer
70
5 Ms. Aron Feingold
Vice President of Investor Relations & Corporate Communications
70
6 Ms. Melissa A. Kelly Behrs
Executive Vice President of Business Operations & Chief Alliance Officer
70
7 Dr. Faye Feller M.D.
Executive Vice President & Chief Medical Officer
70
8 Dr. Andrew J. Grethlein Ph.D.
Executive Vice President & Chief Operating Officer
70
9 Dr. John A. Scarlett M.D.
Chairman of the Board, President & Chief Executive Officer
70
10 Ms. Shannon Odam
Senior Vice President & Chief People Officer
70

Geron Corporation Competitors